Global Febrile Neutropenia Market Statistics and Revenue Forecast 2032
The Febrile Neutropenia Market is witnessing steady expansion as the global burden of cancer continues to rise and chemotherapy remains a primary treatment modality. Febrile neutropenia (FN), characterized by fever and a significant reduction in neutrophil count, is a serious and potentially life-threatening complication in oncology patients. In 2024, the market was valued at US$ 11,123.54...
0 Comments 0 Shares 24 Views 0 Reviews
BIZZNANET https://bizznanet.com